No, a 1 cm margin from the fluorescent specimen is NOT required when using ICG as a guide in breast-conserving surgery.
The established standard for breast-conserving surgery margins in invasive breast cancer is "no ink on tumor," not a 1 cm margin, regardless of whether ICG fluorescence imaging is used. 1, 2
Current Margin Guidelines
The 2024 ESMO guidelines and the SSO-ASTRO consensus clearly establish that:
- For invasive cancer: No tumor at the inked margin is required 1
- For DCIS: A 2 mm margin is preferred 1
The SSO-ASTRO consensus guideline, endorsed by multiple major societies (SSO, ASTRO, ASBS, ASCO) and incorporated into NCCN guidelines, explicitly states that margins wider than "no ink on tumor" do not further reduce local recurrence rates 2. The meta-analysis supporting this guideline found that margins of 1 mm, 2 mm, or 5 mm showed no significant differences in local recurrence rates 2.
ICG Fluorescence Imaging Role
ICG fluorescence imaging serves as an intraoperative margin assessment tool, not a margin width determinant:
- High negative predictive value: Absence of residual fluorescence in the surgical bed predicts negative margins at final pathology with 100% negative predictive value 3
- Sensitivity comparable to frozen section: ICG achieves 81.82% sensitivity for detecting positive margins 4
- Real-time guidance: Helps identify residual tumor tissue intraoperatively 5, 6
The FDA-approved indications for ICG include ophthalmic angiography and hepatic function studies 7, but its use in breast surgery is off-label and serves purely as a visualization adjunct.
Critical Clinical Distinction
ICG fluorescence identifies tumor presence/absence—it does NOT define required margin width. The fluorescent boundary represents tumor extent, and the surgical goal remains achieving "no ink on tumor" at that boundary, not creating an arbitrary 1 cm distance from fluorescence.
Common Pitfall to Avoid
Do not confuse the fluorescent signal boundary with a required margin width. If fluorescence is absent in the surgical bed after excision, this indicates adequate margin clearance according to the "no ink on tumor" standard 3. Creating unnecessarily wide margins (like 1 cm) leads to:
- Increased re-excision rates
- Worse cosmetic outcomes
- No improvement in local recurrence rates 2
The evidence is clear: use ICG to identify tumor extent, then achieve "no ink on tumor" margins—nothing more is required for optimal oncologic outcomes.